Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00229931 · ClinicalTrials.gov registry record · NA
Triamcinolone vs. Laser for Diabetic Macular Edema
A NA study, sponsored by University of Oklahoma.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT00229931 is a NA study that has completed, run by University of Oklahoma. The registered enrollment target is 11 participants.
The verdict
NCT00229931, a NA study, has completed, sponsored by University of Oklahoma.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if intravitreal triamcinolone acetonide (IVTA) injection at the time of cataract surgery will improve visual acuity and decrease post-operative swelling in diabetic patients requiring cataract extraction as compared to the conventional treatment of laser following cataract surgery. The subjects will be followed for 11 visits over 3 year. Visits will occur at screening,1, 3,6,9,12,18,24,30 and 36 months post surgery.
Interventions
- DRUG Triamcinolone acetonide
- PROCEDURE laser
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2005-11 |
| Est. Completion | 2013-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00229931
The ClinicalTrials.gov registry entry for NCT00229931 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Triamcinolone acetonide is the first listed.
NCT00229931 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00229931 about?
NCT00229931 is a clinical study titled "Triamcinolone vs. Laser for Diabetic Macular Edema". The purpose of this study is to determine if intravitreal triamcinolone acetonide (IVTA) injection at the time of cataract surgery will improve visual acuity and decrease post-operative swelling in diabetic patients requiring cataract extraction as compared to the conventional treatment of laser fol...
What is the current status of trial NCT00229931?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2005-11. Estimated completion is 2013-05.
What interventions are being tested in trial NCT00229931?
The interventions under investigation include: Triamcinolone acetonide (DRUG), laser (PROCEDURE).
Who is sponsoring clinical trial NCT00229931?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.